|
91
|
298
|
8w3bA |
Tas-120 covalent structure with fgfr2 molecular brake mutant |
|
79
|
242
|
8v70A |
Crystal structure of the core catalytic domain of human inositol phosphate multikinase in complex with compound 6 |
|
80
|
242
|
8v6yA |
Crystal structure of the core catalytic domain of human inositol phosphate multikinase in complex with compound 3 |
|
84
|
242
|
8v6xA |
Crystal structure of the core catalytic domain of human inositol phosphate multikinase in complex with compound 2 |
|
78
|
242
|
8v74A |
Crystal structure of the core catalytic domain of human inositol phosphate multikinase in complex with compound 10 |
|
77
|
242
|
8v79A |
Crystal structure of the core catalytic domain of human inositol phosphate multikinase in complex with compound 15 |
|
79
|
242
|
8v71A |
Crystal structure of the core catalytic domain of human inositol phosphate multikinase in complex with compound 7 |
|
80
|
242
|
8v76A |
Crystal structure of the core catalytic domain of human inositol phosphate multikinase in complex with compound 12 |
|
79
|
242
|
8v6wA |
Crystal structure of the core catalytic domain of human inositol phosphate multikinase in complex with compound 1 |
|
81
|
242
|
8v75A |
Crystal structure of the core catalytic domain of human inositol phosphate multikinase in complex with compound 11 |
|
82
|
242
|
8v6zA |
Crystal structure of the core catalytic domain of human inositol phosphate multikinase in complex with compound 4 |
|
79
|
242
|
8v78A |
Crystal structure of the core catalytic domain of human inositol phosphate multikinase in complex with compound 14 |
|
81
|
242
|
8v72A |
Crystal structure of the core catalytic domain of human inositol phosphate multikinase in complex with compound 8 |
|
77
|
242
|
8v73A |
Crystal structure of the core catalytic domain of human inositol phosphate multikinase in complex with compound 9 |
|
80
|
242
|
8v77A |
Crystal structure of the core catalytic domain of human inositol phosphate multikinase in complex with compound 13 |
|
97
|
296
|
8scvA |
Crystal structure of irak4-hsa complexed with bms-986126; 6-((5-cyano-2-pyrimidinyl)amino)-n-((2r)-2-fluoro-3-hydroxhylbutyl)-4-(isopropylamino)nicotinamide |
|
94
|
296
|
8sceA |
Crystal structure of irak4-hsa complexed with n-[(2r)-2-fluoro-3-hydroxy-3-methylbutyl]-6-[(5-fluoropyri-yl)amino]-4-[(propan-2-yl)amino]pyridine-3-carboxamide |
|
92
|
295
|
8scwA |
Crystal structure of irak4-hsa complexed with bms-986147; 6-{5-cyano-1h-pyrazolo[3,4-b]pyridin-1-yl}-n-[(2r)-2-fluorroxy-3-methylbutyl]-4-[(propan-2-yl)amino]pyridine-3-carboxamide |
|
77
|
295
|
8scvB |
Crystal structure of irak4-hsa complexed with bms-986126; 6-((5-cyano-2-pyrimidinyl)amino)-n-((2r)-2-fluoro-3-hydroxhylbutyl)-4-(isopropylamino)nicotinamide |
|
102
|
349
|
9o4lA |
Crystal structure of human p38 alpha mapk in complex with mw01-8 -066wh |
|
99
|
291
|
9blhA |
Crystal structure of calcium/calmodulin-dependent protein kinase type ii subunit delta complexed with ribociclib |
|
102
|
349
|
9y8bA |
Human p38 alpha mapk:mw164 pyridazine inhibitor complex |
|
75
|
265
|
9me2A |
Bruton's tyrosine kinase with mutations in the activation loop in complex with compound a110162 |
|
83
|
265
|
9me3A |
Bruton's tyrosine kinase with mutations in the activation loop in complex with compound p301390 |
|
84
|
266
|
9ejrA |
Bruton's tyrosine kinase in complex with compound pti52 |
|
77
|
265
|
9ejxA |
Bruton's tyrosine kinase with mutations in the activation loop in complex with compound pti42 |
|
83
|
265
|
9ejsA |
Bruton's tyrosine kinase with mutations in the activation loop in complex with compound pti52 |
|
80
|
266
|
9ejjA |
Bruton's tyrosine kinase in complex with compound pti55 |
|
37
|
145
|
9cr7A |
Structure of human setd8 in complex with covalent inhibitor am2928 |
|
103
|
347
|
8vxeA |
Structure of p38 alpha (mitogen-activated protein kinase 14) complexed with inhibitor 6 |
|
87
|
293
|
8vxfB |
Structure of casein kinase i isoform delta (ck1d) complexed with inhibitor 15 |
|
84
|
292
|
8vxdA |
Structure of casein kinase i isoform delta (ck1d) complexed with inhibitor 7 |
|
89
|
295
|
8vxfA |
Structure of casein kinase i isoform delta (ck1d) complexed with inhibitor 15 |
|
61
|
247
|
8u4wA |
The crystal structure of a helical domain deleted parp1 in complex with isoindolinone based inhibitor. |
|
42
|
116
|
8ga2A |
Bromodomain of cbp liganded with inhibitor icbp5 |
|
40
|
114
|
8g6tA |
Bromodomain of cbp liganded with inhibitor icbp2 |
|
88
|
324
|
8tjlA |
Egfr kinase in complex with pyrazolopyrimidine covalent inhibitor |
|
88
|
266
|
7ltyA |
Bruton's tyrosine kinase in complex with compound 23 |
|
251
|
871
|
7sfeA |
Human dnmt1(729-1600) bound to zebularine-containing 12mer dsdna and inhibitor gsk3830334a |
|
255
|
871
|
7sffA |
Human dnmt1(729-1600) bound to zebularine-containing 12mer dsdna and inhibitor gsk3852279b |
|
93
|
271
|
6orrA |
Co-crystal structure of human nicotinamiden-methyltransferase (nnmt) in complex with high-affinity alkynyl bisubstrate inhibitor ns1 |
|
81
|
267
|
7suhA |
Structure of chk1 10-pt. mutant complex with lrrk2 inhibitor 15 |
|
78
|
268
|
7suiA |
Structure of chk1 10-pt. mutant complex with lrrk2 inhibitor 22 |
|
76
|
291
|
6oqoA |
Cdk6 in complex with cpd24 n-(5-(6-ethyl-2,6-diazaspiro[3.3]heptan-2-yl)pyridin-2-yl)-5-fluoro-4-(4-methyl-5,6,7,8-tetrahydro-4h-pyrazolo[1,5-a]azepin-3-yl)pyrimidin-2-amine |
|
72
|
263
|
7sujA |
Structure of chk1 10-pt. mutant complex with lrrk2 inhibitor 24 |
|
84
|
269
|
7sufA |
Structure of chk1 10-pt. mutant complex with lrrk2 inhibitor 06 |
|
74
|
291
|
6oqlA |
Cdk6 in complex with cpd13 (r)-5-fluoro-4-(4-methyl-5,6,7,8-tetrahydro-4h-pyrazolo[1,5-a]azepin-3-yl)-n-(5-(4-methylpiperazin-1-yl)pyridin-2-yl)pyrimidin-2-amine |
|
199
|
585
|
7rspA |
Structure of the vps34 kinase domain with compound 14 |
|
132
|
380
|
7rxxA |
Human methionine adenosyltransferase 2a bound to methylthioadenosine and two sulfate in the active site |
|
78
|
299
|
6oqiA |
Cdk2 in complex with cpd14 (5-fluoro-4-(4-methyl-5,6,7,8-tetrahydro-4h-pyrazolo[1,5-a]azepin-3-yl)-n-(5-(4-methylpiperazin-1-yl)pyridin-2-yl)pyrimidin-2-amine) |
